Literature DB >> 25182756

Progesterone receptor interaction with chromatin.

Guillermo P Vicent1, A Silvina Nacht, Cecilia Ballaré, Roser Zaurin, Daniel Soronellas, Miguel Beato.   

Abstract

Understanding how eukaryotic gene regulation works implies unraveling the mechanisms used by transcription factors to access DNA information packaged in chromatin. The current view is that different cell types express different parts of the genome because they are equipped with different sets of transcription factors. A few transcription factors are called pioneer factors because they are able to bind to their sites in nucleosomes and to open up chromatin thus enabling access for other transcription factors, which are unable to recognize DNA packaged in nucleosomes. But it is also possible that the way DNA is organized in chromatin differs between cell types and contributes to cell identity by restricting or enhancing access to specific gene cohorts. To unravel these mechanisms we studied the interaction of progesterone receptor with the genome of breast cancer cells and found that it binds preferentially to sites organized in nucleosomes, which contribute to functional interactions leading to gene regulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25182756     DOI: 10.1007/978-1-4939-1346-6_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Rapid reversible changes in compartments and local chromatin organization revealed by hyperosmotic shock.

Authors:  Ramon Amat; René Böttcher; François Le Dily; Enrique Vidal; Javier Quilez; Yasmina Cuartero; Miguel Beato; Eulàlia de Nadal; Francesc Posas
Journal:  Genome Res       Date:  2018-12-06       Impact factor: 9.043

2.  PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer.

Authors:  Lucie Malbeteau; Julien Jacquemetton; Cécile Languilaire; Laura Corbo; Muriel Le Romancer; Coralie Poulard
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.